Based on the most recent data from Jun 22, 2026, STE's PEG ratio comes in at 0.91. This metric factors in a PE of 25.14 with an earnings growth rate of 27.7%. Relative to the 0.72 average from the past 4 quarters, the PEG ratio has increased by 27%.
Looking at the last ten years, STE's PEG ratio has settled around 1.91 on average. At 0.91, today's PEG ratio sits 52% lower than its historical average. Within the last ten years, the Jun 2019 quarter recorded the highest PEG value at 7.45. At 0.01, the Sep 2023 quarter showed the minimum PEG ratio in this period.
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2026 | 1 | 27.75 | 27.7% |
| 2025 | 0.58 | 36.32 | 62.9% |
| 2024 | 0.23 | 58.7 | 257.9% |
| 2023 | N/A | 178.77 | -57.2% |
| 2022 | N/A | 96.71 | -46.4% |
| 2021 | N/A | 40.88 | -3.1% |
| 2020 | 0.86 | 29.1 | 34% |
| 2019 | 7.13 | 35.66 | 5% |
| 2018 | 0.17 | 27.3 | 165.1% |
| 2017 | N/A | 53.84 | -17.8% |
| 2016 | N/A | 45.25 | -30.8% |
| 2015 | N/A | N/A | 3.2% |
| 2014 | N/A | N/A | -97.2% |
| 2013 | N/A | N/A | 19.1% |
| 2012 | N/A | N/A | N/A |
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | 1 | 27.75 | 27.7% |
| Dec 2025 | 0.68 | 35.21 | 51.9% |
| Sep 2025 | 0.6 | 35.35 | 59.1% |
| Jun 2025 | 0.59 | 36.56 | 62.2% |
| Mar 2025 | 0.58 | 36.32 | 62.9% |
| Dec 2024 | N/A | 43.37 | -17% |
| Sep 2024 | N/A | 55.12 | -20.4% |
| Jun 2024 | 0.23 | 54.21 | 234.7% |
| Mar 2024 | 0.23 | 58.7 | 257.9% |
| Dec 2023 | 0.02 | 38.5 | 2,139.3% |
| Sep 2023 | 0.01 | 39.68 | 7,012.5% |
| Jun 2023 | N/A | 185.93 | -67.9% |
| Mar 2023 | N/A | 178.77 | -57.2% |
| Dec 2022 | N/A | N/A | -109.6% |
| Sep 2022 | N/A | N/A | -102.8% |
Measured against past performance, STE's PEG ratio is above its 3 and 5-year averages, yet it comes in under the 10-year average.
With a PEG of 0.91, STE stands above the Healthcare sector and the industry average. In comparison with its Healthcare sector average of 0.55, STERIS's PEG is 65% higher.
STE has a PEG ratio below that of peer stocks TMO and SYK.
| Stock name | PEG ratio | Market cap |
|---|---|---|
| STE STERIS plc | 0.92 | $19.84B |
| SYK Stryker Corp | 2.15 | $118.84B |
| TMO Thermo Fisher Scientific Inc | 3.9 | $174.35B |
| ECL Ecolab Inc | 90.28 | $75.61B |
| ACH Accendra Health Inc. | N/A | $238.18M |
| CNMD CONMED Corp | N/A | $1.02B |
| MMM 3M Co | N/A | $84.41B |
| JNJ Johnson & Johnson | N/A | $575.69B |
| KMB Kimberly Clark Corp | N/A | $34.5B |
According to Jun 22, 2026 data, STE's PEG ratio sits at 0.91.
Over the last 3 years, STE's PEG ratio has centered around 0.44.
Over the last 5 years, STE's PEG ratio has centered around 0.84.
STE's PEG ratio peaked at 7.45 during the Jun 2019 quarter - the highest in ten years.
STE currently has a PEG ratio 52% below its 10-year average.
Computing the PEG ratio involves dividing the PE ratio by the company's EPS growth rate (YoY TTM). As of Jun 22, 2026, STERIS carries a P/E ratio of 25.14. Earnings grew at 27.7% over the TTM period ending Mar 2026. Applying the formula, this yields a price to earnings growth ratio of 0.91. PEG RATIO(0.91) = PE RATIO(25.14) / EPS GROWTH(27.7%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.